Artificial intelligence and bioinformatics have become key tools for accelerating the development of new biopharmaceuticals, allowing researchers to analyze millions of data, model proteins and orient experimental work with greater precision. Dr. Lisandra Herrera Belén, an academic at the Department of Basic Sciences of Santo Tomás University, Temuco, explained this by developing research that combines pharmaceutical biotechnology, bioinformatic…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Artificial intelligence and bioinformatics have become key tools for accelerating the development of new biopharmaceuticals, allowing researchers to analyze millions of data, model proteins and orient experimental work with greater precision. Dr. Lisandra Herrera Belén, an academic at the Department of Basic Sciences of Santo Tomás University, Temuco, explained this by developing research that combines pharmaceutical biotechnology, bioinformatic…